Vonoprazan fumarate for the management of acid-related diseases
Sign Up to like & getrecommendations! Published in 2017 at "Expert Opinion on Pharmacotherapy"
DOI: 10.1080/14656566.2017.1346087
Abstract: ABSTRACT Introduction: Proton pump inhibitors (PPIs) display a number of limitations and unmet clinical needs that have prompted the development of novel drugs to improve the outcomes of acid-related diseases, including the eradication of H.… read more here.
Keywords: vonoprazan fumarate; fumarate management; related diseases; acid related ... See more keywords